Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies
about
Multiple sites of alternative splicing of the rat fibronectin gene transcriptCharacterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli.The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processMonoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells.Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequences in the fibronectins.A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursorsLocalization of cell surface sites involved in fibronectin fibrillogenesisModulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs.Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells.Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.Transformed human cells release different fibronectin variants than do normal cellsInteraction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin.Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent.Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region.The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin.
P2860
Q33929549-1B473918-BB82-4EF5-B268-B2B4D69C911BQ34142755-7454FE29-448F-43D1-8D90-3E9F90A38094Q34684295-199350BB-332B-4346-A23E-45D2A259AFA4Q35470512-DAFFFB8F-1D65-4DD6-9384-626D36A0BA36Q36216364-9EBC75A1-84B9-41D8-88F7-F4628D86E009Q36218678-9142B290-3CDC-477B-8CD0-309C421C50A9Q36219964-174BFD21-7779-4595-A081-6508BF82B239Q36225282-18941E8E-9ECB-4827-8613-69B52E889BF5Q36273978-DC49FDEC-E9B4-4CBE-813D-5E8181772C99Q36717651-35643A46-04C0-4DCF-9AF9-460893690A31Q36925045-B9A62CC3-8625-4AF5-854A-A1E12E42C9BCQ41015043-9DE6A84A-18E1-486C-8C62-918330FBDBF0Q41347945-FD142D3F-7171-494B-B5F0-A8F9EB159FDAQ41512268-24EB31F9-B4B6-46FE-B502-11A5D2A048B2Q41518871-D84B7406-E3B8-48C4-912F-A22D17D5DDDBQ41572162-7128E997-79B3-4931-B0B0-61146848282EQ41882989-4D0E8B45-375F-4668-838B-8A9E371D49E0Q42158453-0A7803C8-67D9-48B1-BE95-CE616DF2D027Q47263759-360255D8-0377-4136-A09D-A972B2E5F7D5
P2860
Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies
description
1985 nî lūn-bûn
@nan
1985 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Differences in domain structur ...... ith domain-specific antibodies
@ast
Differences in domain structur ...... ith domain-specific antibodies
@en
Differences in domain structur ...... ith domain-specific antibodies
@nl
type
label
Differences in domain structur ...... ith domain-specific antibodies
@ast
Differences in domain structur ...... ith domain-specific antibodies
@en
Differences in domain structur ...... ith domain-specific antibodies
@nl
prefLabel
Differences in domain structur ...... ith domain-specific antibodies
@ast
Differences in domain structur ...... ith domain-specific antibodies
@en
Differences in domain structur ...... ith domain-specific antibodies
@nl
P2093
P1476
Differences in domain structur ...... ith domain-specific antibodies
@en
P2093
P304
P407
P577
1985-04-01T00:00:00Z